ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves Pembrolizumab for First-Line Treatment of HNSCC
June 13, 2019The Food and Drug Administration (FDA) approved pembrolizumab (KEYTRUDA, Merck) for the first-line treatment of patients with metastatic or unresectable recurrent head and neck squamous cell carcinoma (HNSCC). -
NICE rules against first-line use of Ipsen’s Cabometyx
June 06, 2018The National Institute for Health and Care Excellence has issued a preliminary decision rejecting first-line use of Ipsen/Exelixis’ Cabometyx in renal cancer on the NHS. -
Roche says first-line Tecentriq combination meets main goals in Phase III non-squamous NSCLC study
May 30, 2018Roche announced Phase III results Tuesday showing that patients with advanced non-squamous non-small-cell lung cancer (NSCLC) who took the company's PD-L1 inhibitor Tecentriq (atezolizumab) plus chemotherapy as a first-line treatment achieved significantl
Pharma Sources Insight January 2025
